Last update :
19/11/2024
References   References 1516  
Type : Manufacturer

Research teams :
Authors :
Title : Ropivacaine (Naropeine®) - Summary of Product Characteristics
Reference : Mercury Pharmaceuticals Limited 2012

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
injectionClonidine hydrochloride Antihypertensive
Compatible 0,005 >> 0,05 mg/ml + injectionRopivacain hydrochloride 1 - 2 mg/ml
injectionFentanyl citrate Analgesic
Compatible 1 >> 10 µg/ml + injectionRopivacain hydrochloride 1 - 2 mg/ml
injectionMorphine sulfate Analgesic
Compatible 0,02 >> 0,1 mg/ml + injectionRopivacain hydrochloride 1 - 2 mg/ml
injectionRopivacain hydrochloride Local anesthetic
Factors which affect stability pH pH > 6 Induces Degradation
Compatible 1 - 2 mg/ml + injectionClonidine hydrochloride 0,005 >> 0,05 mg/ml
Compatible 1 - 2 mg/ml + injectionFentanyl citrate 1 >> 10 µg/ml
Compatible 1 - 2 mg/ml + injectionMorphine sulfate 0,02 >> 0,1 mg/ml
Compatible 1 - 2 mg/ml + injectionSufentanil citrate 0,0004 >> 0,004 mg/ml
injectionSufentanil citrate Analgesic
Compatible 0,0004 >> 0,004 mg/ml + injectionRopivacain hydrochloride 1 - 2 mg/ml

  Mentions Légales